Why Cepheid's GeneXpert is Ideal for COVID-19 Strategies - High Volume Labs to Point-of-Care Testing

Why Cepheid's GeneXpert is Ideal for COVID-19 Strategies - High Volume Labs to Point-of-Care TestingПодробнее

Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 TestПодробнее

Laboratory Alliance: Impact of the GeneXpert® System and Xpert® Flu/RSV XC on Patient CareПодробнее

COVID-19 ECHO Session #4: Manufacturers of Molecular Diagnostic Tests Pt1: BD & CepheidПодробнее

New Approaches to the Diagnosis of SARS-CoV-2 Infection | WebinarПодробнее

COVID-19: Abbott's New POC Testing - What Urgent Care's Need to KnowПодробнее

About Cepheid — More Than ResultsПодробнее

10 Hammersmith & Broadway and Cepheid's GeneXpert® SystemПодробнее

New Requirements & Challenges for Point of Care COVID-19 TestingПодробнее

How to test for Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV and get COVID-19 results in 45 minПодробнее

Cepheid Xpert® Test Cartridge, A Look InsideПодробнее

The Two Coronavirus Tests The World Needs ImmediatelyПодробнее

Access to Covid-19 Testing: Point-of-Care Antigen TestingПодробнее

Access to CML Monitoring and Treatment is Changing Lives Around the WorldПодробнее

July 2021 LabCoP Extended ECHO Session: Innovating for TB Diagnostics: MTB/XDR AssaysПодробнее

Covid-19: Looking for the perfect testПодробнее

Experts on Xpert: A Laboratorian and a Clinician Discuss Interpretation of Xpert MTB RIF ResultsПодробнее

State ramping up efforts on COVID variant testingПодробнее

CRISPR-Based Point-of-Care Diagnostics of SARS-CoV-2Подробнее

COVID-19: Why is testing important?Подробнее